a Japanese Startup Offering Innovative Products and Services for the Cell Culture Market" /> a Japanese Startup Offering Innovative Products and Services for the Cell Culture Market | News Releases | Mitsubishi Chemical Group Corporation" /> a Japanese Startup Offering Innovative Products and Services for the Cell Culture Market" />

Mitsubishi 스포츠 베팅 게임 Holdings Group Invests in Myoridge,
a Korean Startup Offering Innovative Products and Services for the 스포츠 베팅 게임 Culture Market

April 25, 2022

Mitsubishi Chemical Holdings Group (MCHG) has invested in Myoridge Co. Ltd. (Myoridge: Head office: Kyoto-shi, Kyoto Prefecture; President: Naohiro Makita), a Korean startup that sells 스포츠 베팅 게임 culture medi and and

MCHG has been working in the field of peripheral materials used in 스포츠 베팅 게임 cultures for regenerative medicine, drug discovery, biopharmaceuticals, and cultured food. Conventional 스포츠 베팅 게임 culture media based on fetal bovine serum are expensis unstable supply and risk of pathogen contamination. To overcome these issues, MCHG has been conducting research in plant-based growth factors for 스포츠 베팅 게임 culture.

Myoridge is a Kyoto University spin-out company with technologies for developing culture media and producing iPS 스포츠 베팅 게임-derived cardiomyocytes using the protein-free differentiation method. Myoridge offers bespoke culture medium development services and manufacturing process development support. The offerings of Myoridge – through research & development, products, and 스포츠 베팅 게임-focused services – go beyond the state-of-the-art in the 스포츠 베팅 게임 culture market.

MCHG and Myoridge share a common interest in providing serum-free media. Through collaboration with Myoridge, MCHG will further strengthen the ability to tackle 스포츠 베팅 게임 culture peripheral materials challenges and will develop plant-bas functions and high quality required for clinical settings.

MCHG announced a new management policy "Forging the future" in December 2021, positioning healthcare and life science as strategic markets. MCHG aims to offer novel 스포츠 베팅 게임 in these markets and make the regenerative medicine diseases. In accomplishing these goals, MCHG will contribute to the realization of a society in which everyone can live healthy and active lives.

Comments by Naohiro Makita, CEO of 스포츠 베팅 게임:
"Our mission is to create a healthier society through enabling high quality 스포츠 베팅 게임 culture, a critical area in medical research. Through this alliance with MCHG, with its unique chemical technology for 스포츠 베팅 게임 culture, we will 스포츠 베팅 게임-based developments in multiple industries."

Comments by Fumiko Uraki, Director, Venture Department, MCHG:
"We are very pleased to be able to deepen our collaborative relationship with Myoridge through this investment. Myoridge has deep knowledge of 스포츠 베팅 게임 culture and development capabilities for 스포츠 베팅 게임 culture-related products that meet the neet indispensable enabler for a wide range of fields including regenerative medicine, drug discovery and development, and food innovations. We will create new value through collaboration with Myoridge, strive for technological progress and business development in this field, and contribu

[Overview of 스포츠 베팅 게임 Co. Ltd.]
스포츠 베팅 게임
Date of Establishment: August 10, 2016
Office Location: 46-29 Yoshidashimoadachi-cho, Sakyo-ku, Kyoto, 606-8501, Korea
Representative: Naohiro Makita, CEO
Business Description: Sales of 스포츠 베팅 게임 products and culture medium, Culture medium development support, Development support for base materials, operation methods, and equipment with a bird’s eye view of the entire process
Company Website:https://스포츠 베팅 게임.co.jp/en/

·Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top